GYNecologic Cancer-Related COGnitive Impairment

Description

The goal of this study is to test a home-based and patient-tailored cognitive training intervention among gynecologic cancer patients who have completed chemotherapy and who have experienced cancer-related cognitive impairment.

Conditions

Ovarian Cancer, Endometrial Cancer, Cervical Cancers, Vulvar Cancers, Uterine Cancer, Cervix Cancer, Ovary Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this study is to test a home-based and patient-tailored cognitive training intervention among gynecologic cancer patients who have completed chemotherapy and who have experienced cancer-related cognitive impairment.

A Pilot and Mixed-Methods Study of GYNecologic Cancer-Related COGnitive Impairment

GYNecologic Cancer-Related COGnitive Impairment

Condition
Ovarian Cancer
Intervention / Treatment

-

Contacts and Locations

Chicago

Northwestern University, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Female; ≥18 years of age
  • * Presents to clinic with a confirmed diagnosis of a gynecologic cancer (e.g., ovarian, endometrial, cervical, or vulvar cancer) who have completed adjuvant chemotherapy with at least stable disease at time of screening.
  • * Screen positive for subjective cognitive impairment by answering affirmatively to at least one of three screener questions
  • * Fluent in spoken and written English
  • * Have access to the internet to complete assessments
  • * Patients who have not received chemotherapy
  • * Patients with pre-existing neuropsychiatric disorders that would impact cognitive function, such as dementia, Alzheimer's disease, and schizophrenia.
  • * Patients with non-gynecologic causes of incurable metastatic cancers.
  • * Patients undergoing active interventions in other cognitive trials or patients currently using cognitive training programs such as Brain HQ, Luminosity, Elevate, Peak, Fit Brains, or CogniFit.
  • * Patients with self-report of learning disability or an unwillingness to participate in technology-based cognitive training programs.
  • * Pregnant women or prisoners
  • * Patients with impaired-decision making capacity

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Northwestern University,

Emma Barber, MD, MS, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

2028-12